Termination of the oestrogen-alone arm of the Women's Health Initiative

MeSH terms

• Aged
• Cardiovascular Diseases / prevention & control
• Estrogens, Conjugated (USP) / adverse effects*
• Estrogens, Conjugated (USP) / therapeutic use
• Female
• Hormone Replacement Therapy / adverse effects*
• Hormone Replacement Therapy / methods
• Humans
• Menopause / drug effects*
• Middle Aged
• Osteoporosis, Postmenopausal / prevention & control
• Risk Assessment
• United States
• Women's Health*